RENAL DENERVATION | TECHNOLOGIES SESSION

Sunday, March 9, 2025

9:56 AM – 12:15 PM ET

Moderator(s)

Herbert D. Aronow, MD, MPH

Medical Director, Heart & Vascular Services
Henry Ford Health
Detroit, Michigan, United States

Disclosure(s): Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)
Justin E. Davies, MD, PhD

Cardiologist
Imperial College London
London, England, United Kingdom

Disclosure information not submitted.
Timir Paul, MD, PhD, FACC, FSCAI

Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Herbert D. Aronow, MD, MPH: Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)

Jay Giri, MD, MPH: Boston Scientifiic: Consultant (Ongoing); Inari Medical: Consultant (Ongoing)

Timir Paul, MD, PhD, FACC, FSCAI: No financial relationships to disclose